Sunday, May 12, 2019

Novartis AG is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal muscular atrophy (SMA), a treatment that could cost more than a million dollars, but the gesture comes with strings attached.


from Reuters: Health News https://reut.rs/2Hao93E

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Adolescents from low-income families are more likely than their affluent peers to have risk factors for cardiovascular disease like obesity, inactivity, poor nutrition and tobacco use, a U.S. study suggests… Read More
  • LATEST HEALTH NEWSThe U.S. Centers for Disease Control and Prevention has confirmed 62 cases of acute flaccid myelitis, a rare, polio-like condition that causes weakness in the arms or legs, across 22 states. from Reuters: Health News htt… Read More
  • LATEST HEALTH NEWSChina reported a new African swine fever outbreak in Datong city in Shanxi province, the agriculture ministry said on Wednesday from Reuters: Health News https://ift.tt/2q4DHgh … Read More
  • LATEST HEALTH NEWSU.S. Defense Secretary Jim Mattis on Wednesday visited a former American air base in southern Vietnam that will soon become the biggest-ever U.S. cleanup site for contamination left by the defoliant Agent Orange during the Vi… Read More
  • LATEST HEALTH NEWSChina's vice agriculture minister said on Wednesday that local governments should step up their oversight of large-scale pig farms and breeding farms as another province reported a fresh outbreak of the highly contagious Afri… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner